Sun Pharma board to meet on half-year financial results
Sun Pharmaceutical Industries Limited has announced its Board of Directors will meet on Wednesday, November 5, 2025. The main agenda for the meeting is the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025.
In connection with this, the trading window for the company's securities has been closed. Following a previous communication dated September 22, 2025, the trading window was closed from Wednesday, October 1, 2025, and will remain shut until Friday, November 7, 2025. This closure adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The announcement was made by Anoop Anjanikumar Deshpande, the company secretary and compliance officer, on October 14, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Sun Pharmaceutical Industries publishes news
Free account required • Unsubscribe anytime